Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

Trichocyalides A and B, new inhibitors of alkaline phosphatase activity in bone morphogenetic protein-stimulated myoblasts, produced by Trichoderma sp. FKI-5513.

Fukuda T, Uchida R, Ohte S, Inoue H, Yamazaki H, Matsuda D, Nonaka K, Masuma R, Katagiri T, Tomoda H.

J Antibiot (Tokyo). 2012 Nov;65(11):565-9. doi: 10.1038/ja.2012.70. Epub 2012 Sep 5.

PMID:
22948254
3.

Identification of potential modifiers of Runx2/Cbfa1 activity in C2C12 cells in response to bone morphogenetic protein-7.

Gu K, Zhang L, Jin T, Rutherford RB.

Cells Tissues Organs. 2004;176(1-3):28-40.

PMID:
14745233
4.

Interaction of Tmem119 and the bone morphogenetic protein pathway in the commitment of myoblastic into osteoblastic cells.

Tanaka K, Inoue Y, Hendy GN, Canaff L, Katagiri T, Kitazawa R, Komori T, Sugimoto T, Seino S, Kaji H.

Bone. 2012 Jul;51(1):158-67. doi: 10.1016/j.bone.2012.04.017. Epub 2012 May 2.

PMID:
22579779
5.

5-Prenyltryptophol, a new inhibitor of bone morphogenetic protein-induced alkaline phosphatase expression in myoblasts, produced by Streptomyces colinus subsp. albescens HEK608.

Uchida R, Nakai M, Ohte S, Onaka H, Katagiri T, Tomoda H.

J Antibiot (Tokyo). 2014 Aug;67(8):589-91. doi: 10.1038/ja.2014.44. Epub 2014 May 14. No abstract available.

PMID:
24824820
6.

A kinase domain-truncated type I receptor blocks bone morphogenetic protein-2-induced signal transduction in C2C12 myoblasts.

Namiki M, Akiyama S, Katagiri T, Suzuki A, Ueno N, Yamaji N, Rosen V, Wozney JM, Suda T.

J Biol Chem. 1997 Aug 29;272(35):22046-52.

7.

Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage.

Katagiri T, Yamaguchi A, Komaki M, Abe E, Takahashi N, Ikeda T, Rosen V, Wozney JM, Fujisawa-Sehara A, Suda T.

J Cell Biol. 1994 Dec;127(6 Pt 1):1755-66. Erratum in: J Cell Biol 1995 Feb;128(4):following 713.

8.

Cerinolactone, a hydroxy-lactone derivative from Trichoderma cerinum.

Vinale F, Girona IA, Nigro M, Mazzei P, Piccolo A, Ruocco M, Woo S, Rosa DR, Herrera CL, Lorito M.

J Nat Prod. 2012 Jan 27;75(1):103-6. doi: 10.1021/np200577t. Epub 2011 Dec 23.

PMID:
22196692
9.

Bone morphogenetic protein-2-induced alkaline phosphatase expression is stimulated by Dlx5 and repressed by Msx2.

Kim YJ, Lee MH, Wozney JM, Cho JY, Ryoo HM.

J Biol Chem. 2004 Dec 3;279(49):50773-80. Epub 2004 Sep 21.

10.

Low-level laser irradiation enhances BMP-induced osteoblast differentiation by stimulating the BMP/Smad signaling pathway.

Hirata S, Kitamura C, Fukushima H, Nakamichi I, Abiko Y, Terashita M, Jimi E.

J Cell Biochem. 2010 Dec 15;111(6):1445-52. doi: 10.1002/jcb.22872.

PMID:
20830741
11.

Constitutively active BMP type I receptors transduce BMP-2 signals without the ligand in C2C12 myoblasts.

Akiyama S, Katagiri T, Namiki M, Yamaji N, Yamamoto N, Miyama K, Shibuya H, Ueno N, Wozney JM, Suda T.

Exp Cell Res. 1997 Sep 15;235(2):362-9.

PMID:
9299160
12.

Characterization of bone morphogenetic protein-6 signaling pathways in osteoblast differentiation.

Ebisawa T, Tada K, Kitajima I, Tojo K, Sampath TK, Kawabata M, Miyazono K, Imamura T.

J Cell Sci. 1999 Oct;112 ( Pt 20):3519-27.

13.

Requirement of BMP-2-induced phosphatidylinositol 3-kinase and Akt serine/threonine kinase in osteoblast differentiation and Smad-dependent BMP-2 gene transcription.

Ghosh-Choudhury N, Abboud SL, Nishimura R, Celeste A, Mahimainathan L, Choudhury GG.

J Biol Chem. 2002 Sep 6;277(36):33361-8. Epub 2002 Jun 25. Erratum in: J Biol Chem. 2003 May 2;278(18):16452.

14.

MFH-1 is required for bone morphogenetic protein-2-induced osteoblastic differentiation of C2C12 myoblasts.

Yang XL, Matsuura H, Fu Y, Sugiyama T, Miura N.

FEBS Lett. 2000 Mar 17;470(1):29-34.

15.

Smad1 and smad5 act downstream of intracellular signalings of BMP-2 that inhibits myogenic differentiation and induces osteoblast differentiation in C2C12 myoblasts.

Yamamoto N, Akiyama S, Katagiri T, Namiki M, Kurokawa T, Suda T.

Biochem Biophys Res Commun. 1997 Sep 18;238(2):574-80.

PMID:
9299554
16.

Synergistic effects of different bone morphogenetic protein type I receptors on alkaline phosphatase induction.

Aoki H, Fujii M, Imamura T, Yagi K, Takehara K, Kato M, Miyazono K.

J Cell Sci. 2001 Apr;114(Pt 8):1483-9.

17.

DRAGON, a GPI-anchored membrane protein, inhibits BMP signaling in C2C12 myoblasts.

Kanomata K, Kokabu S, Nojima J, Fukuda T, Katagiri T.

Genes Cells. 2009 Jun;14(6):695-702. doi: 10.1111/j.1365-2443.2009.01302.x. Epub 2009 May 5.

18.

Crystal structure of BMP-9 and functional interactions with pro-region and receptors.

Brown MA, Zhao Q, Baker KA, Naik C, Chen C, Pukac L, Singh M, Tsareva T, Parice Y, Mahoney A, Roschke V, Sanyal I, Choe S.

J Biol Chem. 2005 Jul 1;280(26):25111-8. Epub 2005 Apr 25.

19.

Pitx2 prevents osteoblastic transdifferentiation of myoblasts by bone morphogenetic proteins.

Hayashi M, Maeda S, Aburatani H, Kitamura K, Miyoshi H, Miyazono K, Imamura T.

J Biol Chem. 2008 Jan 4;283(1):565-71. Epub 2007 Oct 20.

20.

Cephalosporolides H and I, Two Novel Lactones from a Marine-Derived Fungus, Penicillium sp.

Li X, Yao Y, Zheng Y, Sattler I, Lin W.

Arch Pharm Res. 2007 Jul;30(7):812-5.

PMID:
17703730

Supplemental Content

Support Center